Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Karlgren

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Targets|December 8, 2006
Tumour-specific expression of CYP2W1: its potential as a drug target in cancer therapyMaria Karlgren, Magnus Ingelman-Sundberg
Toxicology and Applied Pharmacology|July 1, 2005
Novel extrahepatic cytochrome P450sMaria Karlgren, Shin-ichi Miura, Magnus Ingelman-Sundberg
Drug News & Perspectives|February 15, 2007
Novel aspects of drug metabolism and transportLovisa Afzelius, Magnus Ingelman-Sundberg, Maria Karlgren, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2025
Animal product-free formation and cultivation of three-dimensional primary hepatocyte spheroidsEvgeniya Mickols, Rejeen Mohammedamin, Lazaros Primpas, et al.
Molecular Pharmaceutics|July 5, 2013
An integrated in vitro model for simultaneous assessment of drug uptake, metabolism, and effluxEtienne P A Neve, Per Artursson, Magnus Ingelman-Sundberg, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1Maria Karlgren, Maria Backlund, Inger Johansson, et al.
Journal of Proteome Research|July 14, 2015
Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug ExposureAnna Vildhede, Jacek R Wiśniewski, Agneta Norén, et al.
Journal of Pharmaceutical Sciences|October 2, 2020
Expanding the Efflux In Vitro Assay Toolbox: A CRISPR-Cas9 Edited MDCK Cell Line with Human BCRP and Completely Lacking Canine MDR1Christine Wegler, Meryem Gazit, Karolina Issa, et al.
Scientific Reports|February 23, 2017
Intracellular drug bioavailability: a new predictor of system dependent drug dispositionAndré Mateus, Andrea Treyer, Christine Wegler, et al.
Human Genetics|October 14, 2009
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatmentCristina Rodriguez-Antona, Alvin Gomez, Maria Karlgren, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|December 8, 2006
Tumour-specific expression of CYP2W1: its potential as a drug target in cancer therapyMaria Karlgren, Magnus Ingelman-Sundberg
Toxicology and Applied Pharmacology|July 1, 2005
Novel extrahepatic cytochrome P450sMaria Karlgren, Shin-ichi Miura, Magnus Ingelman-Sundberg
Drug News & Perspectives|February 15, 2007
Novel aspects of drug metabolism and transportLovisa Afzelius, Magnus Ingelman-Sundberg, Maria Karlgren, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2025
Animal product-free formation and cultivation of three-dimensional primary hepatocyte spheroidsEvgeniya Mickols, Rejeen Mohammedamin, Lazaros Primpas, et al.
Molecular Pharmaceutics|July 5, 2013
An integrated in vitro model for simultaneous assessment of drug uptake, metabolism, and effluxEtienne P A Neve, Per Artursson, Magnus Ingelman-Sundberg, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1Maria Karlgren, Maria Backlund, Inger Johansson, et al.
Journal of Proteome Research|July 14, 2015
Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug ExposureAnna Vildhede, Jacek R Wiśniewski, Agneta Norén, et al.
Journal of Pharmaceutical Sciences|October 2, 2020
Expanding the Efflux In Vitro Assay Toolbox: A CRISPR-Cas9 Edited MDCK Cell Line with Human BCRP and Completely Lacking Canine MDR1Christine Wegler, Meryem Gazit, Karolina Issa, et al.
Scientific Reports|February 23, 2017
Intracellular drug bioavailability: a new predictor of system dependent drug dispositionAndré Mateus, Andrea Treyer, Christine Wegler, et al.
Human Genetics|October 14, 2009
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatmentCristina Rodriguez-Antona, Alvin Gomez, Maria Karlgren, et al.
Pageof 3